Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Jet2 air hostess high on cocaine caught drug-driving twice in 24 hours - but avoids jail

Isabelle Peck appeared in court

Manchester Evening News

Charity stops working with Government over ‘lacklustre’ monkeypox response

Terrence Higgins Trust believes that without further action the disease could become endemic.

The Independent UK

Covid: Who can get an autumn booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Covid vaccine: When can I get my booster jab?

UK entering a new wave of the virus, experts warn

The Independent UK

Covid booster and flu jabs to be offered to over-50s from Friday

Everyone over the age of 50 will be able to book their Covid booster and flu jab in England from Friday.

Evening Standard

Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund

Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million fund.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Give it another shot: Get the latest COVID-19 booster

Only 10% of Chicagoans have gotten their updated COVID-19 booster. Perhaps we need a jolt of that urgency and desperation we once felt to protect ourselves from coronavirus at the height of the pandemic.

Chicago Sun-Times

Moderna Rallies On Merck Collaboration: Can Drugmaker Replace COVID Vaccine Revenue?

In late 2020, when the world was searching for a vaccine or cure for COVID-19, the price action in Moderna Inc (NASDAQ: MRNA) was discussed frequently on Benzinga's PreMarket Prep show.

Benzinga

Ministry kicks off Pfizer jabs for toddlers

The Ministry of Public Health kicked off the first round of Covid-19 vaccinations for the youngest demographic in the country on Wednesday.

Bangkok Post

India halts production at factory linked to Gambia 'cough syrup' deaths

In tonight's edition: The deaths of dozens of children in Gambia from suspected contaminated medicinal syrups sees Indian authorities shut down production at a pharmaceuticals company in Delhi. And the WHO hopes to start clinical trials for the strain of Ebola behind a deadly outbreak in Uganda. Finally, violent child…

France 24

Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression

Psychedelics biotech company Compass Pathways (NASDAQ: CMPS) announced it will conduct two separate Phase 3 clinical trials to study psilocybin-assisted therapy on Treatment-Resistant Depression (TRD),

Benzinga

FDA authorizes Covid vaccine boosters for children five and above

Moderna vaccine has been approved for children six years and older, while children as young as five can get Pfizer

The Guardian - US

Iodine pills in short supply after Finland updates guideline

Many pharmacies in Finland have run out of iodine tablets a day after the Nordic country’s health ministry recommended that households purchase a single dose in a case of radiation hazard emergency amid increasing fears of a nuclear incident due to Russia’s war in Ukraine

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

FDA authorizes COVID omicron boosters for kids 5 and up

COVID-19 vaccine makers Pfizer Inc. and Moderna Inc. received U.S. regulatory clearances for their omicron-targeted boosters for children as young as 5.

Al Jazeera

US FDA authorises updated booster for children aged 5 and older

Bivalent booster is to increase protection for children as US restrictions ease, schools resume in-person learning.

Axios

FDA, CDC authorize COVID-19 Omicron booster shots for kids

The booster shots are now authorized for children as young as 5 years old.

The Independent UK

FDA clears updated COVID boosters for kids as young as 5

The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Amgen is Our Growth Stock of the Week…

Biotech stocks are outperforming due to attractive valuations and strong catalysts. Amgen (AMGN) is one of the top stocks in the space due to its strong product portfolio, pipeline, and impressive management team. Read on to find out why it's our stock of the week.

Dublin Live

HSE set to open monkeypox vaccination centres next week

The vaccine rollout has been underway since late summer

The Independent UK

'Africa on its own': Little help in epidemics, says official

Africa must plan to respond effectively to disease outbreaks without outside help, a top public health official said Wednesday, warning that the continent of 1.3 billion people is “on its own” during pandemics

Irish Mirror

Boots offering 2-in-1 flu and Covid vaccination appointments amid winter wave fears

All those eligible for their next Covid vaccine can avail of it alongside their Flu vaccine in stores nationwide

The Hindu

Gambia cough syrup-related deaths | CDSCO to examine Maiden Pharma’s role, Haryana sends notice to firm

Haryana Health Minister Anil Vij said that authorities inspected a Maiden Pharmaceuticals factory in Sonepat and found 12 violations of good practices, following which production was ordered stopped

Reuters

India finds violations at factory linked to Gambia children deaths -state minister

Authorities in India have stopped production of cough syrup at a factory linked to children's deaths in Gambia after they found violations, a state minister told Reuters partner ANI on Wednesday.

The Times of India

Coronavirus: India's first antidote against COVID 'VINCOV-19' ready for phase 3 clinical trial

The phase 3 clinical trial of the first antidote against COVID, VINCOV-19, is expected to begin soon as the drug is ready for market authorization. VINCOV-19 is a joint effort of the University of Hyderabad (UoH), the Centre for Cellular and Molecular Biology (CCMB) and VINS Bioproducts Limited.

1 … 121 122 123 124

People

Jaimini DesaiJaimini Desai

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.